Jade Biosciences (JBIO) Assets Average (2021 - 2026)

Jade Biosciences (JBIO) has 6 years of Assets Average data on file, last reported at $334.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 345.16% year-over-year to $334.6 million; the trailing twelve-month figure through Mar 2026 stood at $334.6 million (up 345.16% YoY), and the FY2025 full-year result was $211.3 million, up 111.06% from the prior year.
• Assets Average for Q1 2026 stood at $334.6 million, up from $276.1 million in the prior quarter.
• Across five years, Assets Average topped out at $334.6 million in Q1 2026 and bottomed at $75.2 million in Q1 2025.
• The 5-year median for Assets Average is $141.5 million (2022), against an average of $155.1 million.
• The widest annual swing landed in 2024, when Assets Average tumbled 38.96%; it then jumped 345.16% in 2026.
• A 5-year view of Assets Average shows it stood at $141.5 million in 2022, then slipped by 5.18% to $134.1 million in 2023, then sank by 38.96% to $81.9 million in 2024, then jumped by 237.22% to $276.1 million in 2025, then gained by 21.18% to $334.6 million in 2026.
• The last three Assets Average figures came in at $334.6 million (Q1 2026), $276.1 million (Q4 2025), and $213.2 million (Q3 2025), per Business Quant data.

Peer Comparison